Chinese Herbal Medicines
From January 2020 Chinese Herbal Medicines (CHM) will become an open access journal. Authors who publish in CHM will be able make their work immediately, permanently, and freely accessible.
CHM continues with the same aims and scope, editorial team, and rigorous peer review.
Chinese Herbal Medicines (CHM) is the official, peer-reviewed journal of Tianjin Institute of Pharmaceutical Research and Institute of Medicinal Plant Development, Chinese Academy of Medical Sciences.
CHM aims to provide a forum for the studies on Chinese herbal medicines, traditional medicines, and natural products. The journal includes studies on active ingredients and complex formulations of herb medicines in medicinal resource, phytochemistry, pharmacology, toxicology, pharmacokinetics, and therapeutic function through experimental and clinical trials. The aim of the journal is to disseminate the latest developments in pharmaceutical sciences to researchers and practitioners.
Article types accepted by CHM include research articles, review papers, short communications, and book reviews. The editorial committee is composed of 74 experts, among which 12 are academicians of Chinese Academy of Engineering and Social Sciences.
CHM is included in China Academic Journals Integrated Online Database, Chemical Abstracts Service (CAS), Index Copernicus (IC), Ulrich's Periodicals Directory (UPD). It is also indexed by Global Health and CAB Abstract.